AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2022
Nov 15, 2022
31201_dirs_2022-11-14_07ecaa3e-ab25-464e-a281-448558964191.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2022-11-10
Reporting Person: Weill David (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-10 | Common Stock | M | 21645 | $16.00 | Acquired | 35145 | Direct |
| 2022-11-10 | Common Stock | S | 21645 | $56.00 | Disposed | 13500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-10 | Stock Option (Right to Buy) | $16.00 | M | 21645 | Disposed | 2029-05-01 | Common Stock (21645) | Direct |
Footnotes
F1: The option is fully vested.
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Earnings Release
2026
Feb 24
Director's Dealing
2026
Feb 20